Nefopam
- Generic Name
- Nefopam
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H19NO
- CAS Number
- 13669-70-0
- Unique Ingredient Identifier
- 4UP8060B7J
- Background
Nefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering. Nefopam has been investigated for the prevention of Kidney Transplantation.
- Indication
用于术后镇痛、癌痛、急性外伤痛。亦可用于急性胃炎、胆道蛔虫症、输尿管结石等内脏平滑肌收缩绞痛；局部麻醉、针麻等麻醉辅助用药。
- Associated Conditions
- Pain
- Associated Therapies
- -
Efficacy of Intravenous Nefopam, Dexmedetomidine, and Meperidine in Preventing Post-Spinal Anesthesia Shivering in Adult Patients Undergoing Lower Abdominal and Lower Limb Surgeries.
- Conditions
- Interventions
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Kasr El Aini Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT06627816
- Locations
- 🇪🇬
Kasr Al Aini Hospitals, Cairo, Egypt
Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty (NEFARTHRO)
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 546
- Registration Number
- NCT06349798
- Locations
- 🇫🇷
Anaesthesia - Intensive care, Poitiers, France
🇫🇷Anesthesia - intensive care, Tours, France
Nefopam as a Multimodal Analgesia for Thoracic Surgery
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- Kangbuk Samsung Hospital
- Target Recruit Count
- 46
- Registration Number
- NCT05173337
- Locations
- 🇰🇷
Eunah Cho, Seoul, Korea, Republic of
Adjuvant Continuous Infusion of Nefopam Versus Standard of Care in Mechanically Ventilated Critically Ill Patients: Randomized Double-blind Controlled Study
- First Posted Date
- 2021-10-08
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 60
- Registration Number
- NCT05071352
- Locations
- 🇪🇬
Cairo University Hospitals (Kasr Alainy), Cairo, Egypt
Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients
- Conditions
- Interventions
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 60
- Registration Number
- NCT04685577
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery
- Conditions
- Interventions
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Target Recruit Count
- 80
- Registration Number
- NCT03619538
Effectiveness of Nefopam in Breast Cancer Surgery
- Conditions
- Interventions
- First Posted Date
- 2016-10-31
- Last Posted Date
- 2018-01-11
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 88
- Registration Number
- NCT02949310
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of
Nefopam/Fentanyl Postoperative Intravenous Patient-Controlled-Analgesia
- First Posted Date
- 2015-11-04
- Last Posted Date
- 2015-11-05
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 73
- Registration Number
- NCT02596269
Combination Effect of Nefopam With Propacetamol for Postoperative Pain After Thyroidectomy
- First Posted Date
- 2015-10-16
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 84
- Registration Number
- NCT02577068
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
Postoperative Analgesic Effect of Nefopam
- First Posted Date
- 2015-09-28
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 78
- Registration Number
- NCT02561494
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.